ImmunityBio, Inc. (IBRX)
10.28
+1.00
(+10.83%)
USD |
NASDAQ |
Oct 02, 16:00
10.30
+0.02
(+0.15%)
After-Hours: 20:00
ImmunityBio Market Cap : 10.83B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.83B |
| October 01, 2026 | 9.774B |
| September 30, 2026 | 9.942B |
| September 29, 2026 | 9.300B |
| September 28, 2026 | 8.973B |
| September 25, 2026 | 8.889B |
| September 24, 2026 | 9.100B |
| September 23, 2026 | 9.089B |
| September 22, 2026 | 9.784B |
| September 21, 2026 | 8.900B |
| September 18, 2026 | 8.931B |
| September 17, 2026 | 8.910B |
| September 16, 2026 | 8.331B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.815B |
| September 11, 2026 | 8.331B |
| September 10, 2026 | 8.131B |
| September 09, 2026 | 8.489B |
| September 08, 2026 | 8.731B |
| September 04, 2026 | 8.510B |
| September 03, 2026 | 8.626B |
| September 02, 2026 | 8.373B |
| September 01, 2026 | 8.289B |
| August 31, 2026 | 8.373B |
| August 28, 2026 | 8.478B |
| Date | Value |
|---|---|
| August 27, 2026 | 8.847B |
| August 26, 2026 | 8.689B |
| August 25, 2026 | 8.626B |
| August 24, 2026 | 7.983B |
| August 21, 2026 | 8.205B |
| August 20, 2026 | 8.257B |
| August 19, 2026 | 8.563B |
| August 18, 2026 | 8.131B |
| August 17, 2026 | 8.342B |
| August 14, 2026 | 7.973B |
| August 13, 2026 | 8.057B |
| August 12, 2026 | 8.152B |
| August 11, 2026 | 8.004B |
| August 10, 2026 | 7.889B |
| August 07, 2026 | 8.047B |
| August 06, 2026 | 7.710B |
| August 05, 2026 | 7.593B |
| August 04, 2026 | 7.279B |
| August 03, 2026 | 7.488B |
| July 31, 2026 | 7.509B |
| July 30, 2026 | 7.803B |
| July 29, 2026 | 7.153B |
| July 28, 2026 | 7.300B |
| July 27, 2026 | 7.321B |
| July 24, 2026 | 7.436B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 75.81B |
| Sarepta Therapeutics, Inc. | 1.848B |
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
Market Cap Related Metrics
| PS Ratio | 62.24 |
| PEG Ratio | -0.1099 |
| Price | 10.28 |
| Earnings Yield | -9.42% |
| PEGY Ratio | -0.1099 |